Real-World study shows benralizumab helps control severe asthma
NCT ID NCT05603845
First seen Mar 22, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study looked at 291 adults with severe eosinophilic asthma who were starting benralizumab (Fasenra). Researchers tracked how well the drug controlled their asthma symptoms over time using patient questionnaires. The goal was to see if benralizumab improves asthma control in real-world settings across countries in the Gulf, Latin America, and India.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Bogotá, Colombia
-
Research Site
Bucaramanga, Colombia
-
Research Site
Ibague, Colombia
-
Research Site
Pereira, Colombia
-
Research Site
Santiago de los Caballeros, Dominican Republic
-
Research Site
Santo Domingo, Dominican Republic
-
Research Site
Ahmedabad, India
-
Research Site
Ajmer, India
-
Research Site
Chennai, India
-
Research Site
Delhi, India
-
Research Site
Hyderabad, India
-
Research Site
Jaipur, India
-
Research Site
Kolkata, India
-
Research Site
Pune, India
-
Research Site
Secundrabad, India
-
Research Site
Vadodara, India
-
Research Site
Sabah Al Salem, Kuwait
-
Research Site
Muscat, Oman
-
Research Site
Doha, Qatar
-
Research Site
Jeddah, Saudi Arabia
-
Research Site
Riyadh, Saudi Arabia
-
Research Site
Abu Dhabi, United Arab Emirates
-
Research Site
Al Ain City, United Arab Emirates
-
Research Site
Dubai, United Arab Emirates
Conditions
Explore the condition pages connected to this study.